Vaccines in the pipeline: The path from development to use in the United States

Pediatric Annals

Volumn 42, Issue 8, 2013, Pages 146-152

  Pickering, Larry K ^a,b   Walton, L Reed ^c  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ARTICLE; CHLAMYDIA; CLOSTRIDIUM DIFFICILE; DRUG APPROVAL; DRUG MARKETING; DRUG MONITORING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HAEMOPHILUS INFLUENZAE TYPE A; HEALTH CARE PERSONNEL; HERPES ZOSTER; HUMAN; NEISSERIA MENINGITIDIS; ORGANIZATION; PSEUDOMONAS AERUGINOSA; PUBLIC HEALTH SERVICE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VACCINE PRODUCTION; VARICELLA ZOSTER VIRUS;

ADVISORY COMMITTEES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COMMUNICABLE DISEASE CONTROL; DRUG APPROVAL; HUMANS; IMMUNIZATION SCHEDULE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VACCINATION; VACCINES;

EID: 84882746232     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20130723-08     Document Type: Article

References (37)

1. Nabel GJ. Designing tomorrow's vaccines. N Engl J Med. 2013;368:551-560.
2. National Vaccine Advisory Committee. United States Vaccine Research: a delicate fabric of public and private collaboration. Pediatrics. 1997;100(6):1015-1020.
3. New Vaccine Development: Establishing Priorities-Volume 1: Diseases of Importance in the United States. Institute of Medicine. 1986, National Academies Press. Available at: www.nap.edu/catalog.php?record_id=12085#toc. Accessed July 8, 2013.
4. Vaccines for the 21st Century: A Tool for Decisionmaking. Institute of Medicine; 2000. National Academies Press. Available at: www.nap.edu/catalog.php?record_id=5501. Accessed July 8, 2013.
5. Ranking vaccines: a prioritization framework: phase I: demonstration of concept and a software blueprint. Institute of Medicine; 2012. Available at: www.nap.edu/catalog.php?record_id=13382. Accessed July 8, 2013.
6. United States Public Health Service Act (1944), Amended. Title 42: The Public Health and Welfare. Chapter 6A: Public Health Service. Sub-Chapter II: General Powers and Duties. Part F: Licensing of Biological Products and Clinical Laboratories. Section 262: Regulation of Biological Products. Available at: www.fda.gov/RegulatoryInformation/Legislation/ucm149278.htm. Accessed July 8, 2013.
7. Vaccine Product Approval Process. US Food and Drug Administration. Available at: www.fda.gov/BiologicsBloodVaccines/DevelopmentApprovalProcess/BiologicsLicenseApplicationsBLAProcess/ucm133096.htm. Accessed July 8, 2013.
8. Vaccine and Related Biological Products Advisory Committee. US Food and Drug Administration. Available at: www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee. Accessed July 8, 2013.
9. FY 2011 Performance Report to the President and Congress for the Prescription Drug User Fee Act. 2012. US Food and Drug Administration. Available at: www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/UserFeeReports/PerformanceReports/PDUFA/UCM294101.pdf. Accessed July 8, 2013.
10. Fast Track, Accelerated Approval, and Priority Review. US Food and Drug Administration. Available at: www.fda.gov/forconsumers/ byaudience/forpatientadvocates/speedingaccesstoimportantnewtherapies/ucm128291.htm. Accessed July 8, 2013.
11. Stafford RS. Regulating off-label drug use- rethinking the role of the FDA. N Engl J Med. 2008;358:1427-1429.
12. Vaccine Adverse Event Reporting System. Centers for Disease Control and Prevention. Available at: www.cdc.gov/vaccinesafety/Activities/vaers.html. Accessed July 8, 2013.
13. Varricchio F, Iskander J, Destefano F, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J. 2004;23:287-294.
14. National Vaccine Injury Compensation Program. U.S. Department of Health and Human Services. Health Resources and Services Administration. Available at: www.hrsa.gov/vaccinecompensation/index.html. Accessed July 8, 2013.
15. The Vaccine Safety Datalink. Available at: www.cdc.gov/vaccinesafety/Activities/VSD.html. Accessed July 8, 2013.
16. Clinical Immunization Safety Assessment (CISA) Network. Available at: www.cdc.gov/vaccinesafety/activities/cisa.html. Accessed July 8, 2013.
17. Nguyen M, Ball R, Midthun K, Lieu TA. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):291-297.
18. Smith JC, Snider DE, Pickering LK. Immunization policy development in the United States: the role of the advisory committee on immunization practices. Ann Intern Med. 2009;150(1):45-49.
19. Advisory Committee on Immunization Practices. Centers for Disease Control and Prevention. Available at: www.cdc.gov/vaccines/acip/ index.html. Accessed July 8, 2013.
20. GRADE Working Group. Available at: www.gradeworkinggroup.org. Accessed July 8, 2013.
21. GRADE Evidence Tables: recommendations in MMWR. Centers for Disease Control and Prevention. Available at: www.cdc.gov/vaccines/acip/recs/GRADE/table-refs.html. Accessed July 8, 2013.
22. Ahmed F, Temte JL, Campos-Outcalt D, Schünemann HJ. Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC). Vaccine. 2011;29:9171-9176.
23. Vaccine Status Tables. Red Book Online. American Academy of Pediatrics. Available at: aapredbook.aappublications.org/site/news/vaccstatus.xhtml. Accessed July 8, 2013.
24. Pickering LK, ed. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. American Academy of Pediatrics; Elk Grove Village, IL: 2012.
25. Röhn TA, Bachmann MF. Vaccines against non-communicable diseases. Curr Opin Immunol. 2010;22:391-396.
26. Sanofi Pasteur R & D Portfolio. Available at: www.sanofipasteur.com/?codePage=PAG_22_1288245984593&codeRubrique=22. Accessed July 17, 2013.
27. Novartis Vaccines: Pipeline. Available at: www.novartisvaccines.com/products-diseases/pipeline.shtml. Accessed July 17, 2013.
28. Cohn AC, MacNeil JR, Clark TA, et al, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR02):1-28.
29. Merck Pipeline. Available at: www.merck.com/research/pipeline/home.html. Accessed July 17, 2013.
30. Fowler VG, Allen KB, Moreira ED, et al. Effect of an investigational vaccine preventing Staphylococcus aureus infections after cardiothoracic surgery. JAMA. 2013;309(13):1368-1378.
31. GlaxoSmithKline: Our Product Pipeline. Available at: www.gsk.com/research/our-prod-uct-pipeline.html. Accessed July 17, 2013.
32. Pfizer Pipeline. Available at: www.pfizer.com/sites/default/files/product-pipeline/pipeline_2013_0509.pdf. Accessed July 17, 2013.
33. Markowitz LE, Dunne EF, Saraiya M, et al, Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR02):1-24.
34. FDA licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR. 2010;59(20):630-632.
35. National Academies Press. Ranking vaccines: a prioritization framework: phase I: demonstration of concept and a software blueprint (2012). Available at: books.nap.edu/openbook. php?record_id=13382&page=38. Accessed on July 18, 2013.
36. Hinshaw AS. The childhood immunization schedule and safety: stakeholder concerns, scientific evidence, and future studies. Available at: www.cdc.gov/vaccines/acip/meetings/ downloads/slides-feb-2013/IOM-Hinshaw.pdf. Accessed July 17, 2013.
37. US Centers for Disease Control and Prevention. Vaccine Recommendations of the ACIP.Available at: www.cdc.gov/vaccines/pubs/ACIP-list-by-date.htm. Accessed on July 18, 2013.